|
Post by roseylv on Feb 1, 2017 16:30:50 GMT -5
The issuance of this type of PR is basically like old news. I'm content that they actually followed through and updated the titration pack and are moving forward with the sales team but come on.....
What a boring PR! Stock will trade downward without anything material. We all know what sales have been like :-(. I'm still holding my position but not my breath. Come on MNKD do something already!!!!
|
|
|
Post by dreamboatcruise on Feb 1, 2017 16:37:29 GMT -5
If this is all than only true MNKD-fans will cheer up and the market will ignore this = no increase in share price today. If this ad-hoc conf call made some shorts be afraid, then this news will make them focus on other companies again. Can't imagine why this conference call would have made shorts afraid. Share price certainly doesn't reflect any fear in shorts. The fact shares aren't being returned to those that have them on loan also would indicate that.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 1, 2017 16:38:24 GMT -5
well as some said, if the management is patting themselves for hiring a few sales people and doing text book moves ( not resulting in increased sales )...this deserves a PR and a conference call.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 1, 2017 16:42:40 GMT -5
Lets at least hear what management has to say. Mannkind web site shows yet another new sales position posted today for Wilmington DE. All of us longs are frustrated but we have waited this long, give it another month or two and lets see what the new sales team can do with better sample and titration packs.
|
|
|
Post by dreamboatcruise on Feb 1, 2017 16:46:50 GMT -5
It's interesting that they say the old titration pack accounts for 25% of weekly dispensing. That would either indicate many aren't sticking with Afrezza... or that perhaps people are finding the "titration" pack is simply a cheaper way of meeting their ongoing need for Afrezza. Wonder if there is any restriction on continued purchase of "titration" packs, both old and new, and what effect that would have on average selling price. If the titration packs are used on a regular basis and last longer for a user, reducing the copays, that would be attractive to patients, but if priced based on total volume of insulin, might be unattractive to the insurers because of the fewer copays.
Having fixed cartridge sizes does make pricing of packs a rather complicated issue compared to injectable pens, though perhaps if MNKD is clever there is some way they can do it that will help them gain market share rather than hinder.
|
|
|
Post by dreamboatcruise on Feb 1, 2017 16:50:05 GMT -5
well as some said, if the management is patting themselves for hiring a few sales people and doing text book moves ( not resulting in increased sales )...this deserves a PR and a conference call. Some are presuming the PR is what the conference call is about. Probably an equal number of us believe it is something else. Personally the PR to me, tips me slightly more to believing it will be something about financing/delisting that will not sound good... and PR was released ahead to basically say "hey, we are planning to be around long term and keep plowing ahead with the plan." my 1 cent worth (can't avoid 2 cents at this share price).
|
|
|
Post by kbrion77 on Feb 1, 2017 16:55:07 GMT -5
well as some said, if the management is patting themselves for hiring a few sales people and doing text book moves ( not resulting in increased sales )...this deserves a PR and a conference call. Some are presuming the PR is what the conference call is about. Probably an equal number of us believe it is something else. Personally the PR to me, tips me slightly more to believing it will be something about financing/delisting that will not sound good... and PR was released ahead to basically say "hey, we are planning to be around long term and keep plowing ahead with the plan." my 1 cent worth (can't avoid 2 cents at this share price). That is all the street cares about. Matt wouldn't tip anything off right now about dilution or delisting but if he did this thing will crater.
|
|